-

Hims & Hers Expands Customizable, Compounded Skincare Offerings With Hims Overnight Anti-Aging Duo, Hers Clear Skin System

New offerings include a personalized, compounded prescription cream to ensure high clinical efficacy

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”) (NYSE: HIMS), the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to consumers, recently launched Hims Overnight Anti-Aging Duo and a customized Hers Clear Skin System.

“Skincare is a lifelong journey and certainly not a one-size-fits-all proposition,” said Hilary Coles, co-founder and SVP of Brand & Innovation, Hims & Hers. “We have worked hand-in-hand with experienced dermatologists to offer customizable prescription creams that can be used both individually and in combination with other Hims & Hers skincare offerings so our customers have the opportunity to experience their best skin possible.”

Hims Overnight Anti-Aging Duo was developed with dermatologists to combat wrinkles and sun damage while moisturizing and nourishing skin. It includes a customizable prescription Anti-Aging Cream mixed with three clinical ingredients and available in three different strengths, as well as the nonprescription Goodnight Wrinkle Cream made with hyaluronic acid. Both the customizable prescription Anti-Aging Cream and Goodnight Wrinkle Cream will also continue to be available for purchase individually on ForHims.com. Those consumers looking to purchase the prescription cream -- as part of the Duo or individually -- will need to first complete a consultation with a healthcare provider through the Hims & Hers platform to see if a prescription treatment is medically recommended and will be able to purchase the prescription cream only if deemed appropriate by the healthcare provider. The Goodnight Wrinkle Cream is available for purchase directly from Hims without a prescription.

Hers’ Clear Skin System provides consumers with the ability to have both clean and hydrated skin with the support of an experienced medical professional. If appropriate, customers can receive a customizable prescription acne cream tailored to their individual needs with a blend of up to five powerhouse ingredients: tretinoin, clindamycin, azelaic acid, zinc pyrithione and niacinamide, as well as the Deep Sea Cleanser, a gentle, hydrating cleanser made with red seaweed extract and rosehip; and the Tidal Wave Moisturizer, made with hyaluronic acid and squalane to hydrate without clogging pores.

For more information on Hims skincare, please visit https://www.forhims.com/skin-care and on Hers skincare, please visit https://www.forhers.com/skin-care.

About Hims & Hers

Hims & Hers is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to primary care, mental health, sexual health, dermatology, and more. Launched in November 2017, the company also offers thoughtfully created and curated health and wellness products. With products and services available across all 50 states and Washington, D.C., Hims & Hers is able to provide access to quality, convenient and affordable care for all Americans. Hims & Hers was founded by CEO Andrew Dudum, Hilary Coles, Jack Abraham and Joe Spector at venture studio Atomic in San Francisco, California. For more information about Hims & Hers, please visit forhims.com and forhers.com.

Contacts

Linda O'Connor
press@forhims.com

Hims & Hers Health, Inc.

NYSE:HIMS

Release Summary
Hims & Hers, a multi-specialty telehealth platform, recently launched Hims Overnight Anti-Aging Duo and a customized Hers Clear Skin System.
Release Versions

Contacts

Linda O'Connor
press@forhims.com

More News From Hims & Hers Health, Inc.

Dr. Andrew Huberman Joins Hims & Hers Board of Directors

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading global health and wellness platform, announced the appointment of Andrew Huberman, Ph.D., to the company’s Board of Directors. Dr. Huberman is a world-renowned neuroscientist and tenured professor in the Departments of Neurobiology and Ophthalmology at Stanford University School of Medicine. He has authored or co-authored more than 75 peer-reviewed articles in respected scientific journals...

Hims & Hers Health, Inc. Reports Third Quarter 2026 Financial Results

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS), the leading global health and wellness platform, today announced financial results for the third quarter ended September 30, 2026. “In healthcare, whoever owns the customer relationship wins, and that’s exactly what we’re building toward at Hims & Hers. Today, customers want real choice, real value, and a care team that knows them,” said Andrew Dudum, co-founder and CEO. “Everythin...

Lilly and Hims & Hers expand access to FDA-approved Lilly medicines

INDIANAPOLIS--(BUSINESS WIRE)--Eli Lilly and Company (NYSE: LLY) and Hims & Hers Health, Inc. (NYSE: HIMS) today announced an agreement to help expand access to Zepbound (tirzepatide) and Foundayo (orforglipron). Through the agreement, eligible patients who receive a prescription from a licensed provider on the Hims & Hers platform will access the same self-pay prices available to any patient without leaving the Hims & Hers platform. The agreement brings together Lilly’s obesity med...
Back to Newsroom